1. C. Bucolo, G.M. Leggio, F. Drago, S. Salomone, Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats, Biochemical pharmacology 84(1) (2012) 88-92.
2. C. Bucolo, K.W. Ward, E. Mazzon, S. Cuzzocrea, F. Drago, Protective effects of a coumarin derivative in diabetic rats, Investigative ophthalmology & visual science 50(8) (2009) 3846-3852.
3. F. Ishizuka, M. Shimazawa, N. Umigai, H. Ogishima, S. Nakamura, K. Tsuruma, H. Hara, Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice, European journal of pharmacology 703(1-3) (2013) 1-10.
4. N. Tong, Z. Zhang, Y. Gong, L. Yin, X. Wu, Diosmin protects rat retina from ischemia/reperfusion injury, Journal of ocular pharmacology and therapeutics 28(5) (2012) 459-466.
5. P.-G. Pietta, Flavonoids as antioxidants, Journal of natural products 63(7) (2000) 1035-1042.
6. VT. Mostafa, T.H. Anis, S. Ghazi, A.R. El‐Nashar, H. Imam, I.A. Osman, Reactive oxygen species and antioxidants relationship in the internal spermatic vein blood of infertile men with varicocele, Asian journal of andrology 8(4) (2006) 451-454.
7.K.M. Venardos, D.M. Kaye, Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review, Current medicinal chemistry 14(14) (2007) 1539-1549.
8.T.M. Holland, P. Agarwal, Y. Wang, S.E. Leurgans, D.A. Bennett, S.L. Booth, M.C. Morris, Dietary flavonols and risk of Alzheimer dementia, Neurology 94(16) (2020) e1749-e1756.
9.L. Kong, C. Luo, X. Li, Y. Zhou, H. He, The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits, Lipids in Health and Disease 12(1) (2013) 115.
10. M.J. Park, E.K. Lee, H.-S. Heo, M.-S. Kim, B. Sung, M.K. Kim, J. Lee, N.D. Kim, S. Anton, J.S. Choi, The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-κ B via nuclear factor-inducing kinase/I κ B kinase and mitogen-activated protein kinase pathways, Journal of medicinal food 12(2) (2009) 351-358.
11.T.A. Yap, M.D. Garrett, M.I. Walton, F. Raynaud, J.S. de Bono, P. Workman, Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises, Current opinion in pharmacology 8(4) (2008) 393-412.
12. D. King, D. Yeomanson, H.E. Bryant, PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma, Journal of pediatric hematology/oncology 37(4) (2015) 245-251.
13. J. Peltier, A. O'Neill, D.V. Schaffer, PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation, Developmental neurobiology 67(10) (2007) 1348-1361.
14.V.A. Rafalski, A. Brunet, Energy metabolism in adult neural stem cell fate, Progress in neurobiology 93(2) (2011) 182-203.
15. H.-Y. Man, Q. Wang, W.-Y. Lu, W. Ju, G. Ahmadian, L. Liu, S. D'Souza, T.P. Wong, C. Taghibiglou, J. Lu, Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons, Neuron 38(4) (2003) 611-624.
16. L. Sui, J. Wang, B.-M. Li, Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex, Learning & memory 15(10) (2008) 762-776.
17. R. Kimura, M. Okouchi, H. Fujioka, A. Ichiyanagi, F. Ryuge, T. Mizuno, K. Imaeda, N. Okayama, Y. Kamiya, K. Asai, Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway, Neuroscience 162(4) (2009) 1212-1219.
18. X. Wu, L. Long, J. Liu, J. Zhang, T. Wu, X. Chen, B. Zhou, T.Z. Lv, Gambogic acid suppresses inflammation in rheumatoid arthritis rats via PI3K/Akt/mTOR signaling pathway, Molecular medicine reports 16(5) (2017) 7112-7118.